Company news
iBio, Inc. news in 2021
iBio, Inc.'s news releases, calls and decks from 2021, newest first.
iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022
December 21, 2021
iBio Announces Partial Adjournment of Annual Meeting to December 22
December 9, 2021
iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors
November 14, 2021
iBio Acquires FastPharming Manufacturing Facility®
November 2, 2021
iBio Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting to be Held on December 9
October 25, 2021
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
September 26, 2021
iBio Appoints William D. Clark to its Board of Directors
August 25, 2021
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
July 14, 2021
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
July 7, 2021
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update
May 16, 2021
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021
May 9, 2021
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program
May 5, 2021
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement
May 3, 2021
iBio Appoints Robert M. Lutz as Chief Financial & Business Officer
February 15, 2021
Decks in 2021
- Investor Presentation (August 2021)
Investor deck · 32 slides · Aug 30, 2021